HK1009938A1 - Product comprising rapamycin or particular derivatives and an nmda or ampa antagonist for use for the treatment of epilepsy or huntington's disease, and the use of rapamycin or particular derivatives for the manufacture of a medicament for the treatment of epilepsy or huntington's disease - Google Patents

Product comprising rapamycin or particular derivatives and an nmda or ampa antagonist for use for the treatment of epilepsy or huntington's disease, and the use of rapamycin or particular derivatives for the manufacture of a medicament for the treatment of epilepsy or huntington's disease

Info

Publication number
HK1009938A1
HK1009938A1 HK98110870A HK98110870A HK1009938A1 HK 1009938 A1 HK1009938 A1 HK 1009938A1 HK 98110870 A HK98110870 A HK 98110870A HK 98110870 A HK98110870 A HK 98110870A HK 1009938 A1 HK1009938 A1 HK 1009938A1
Authority
HK
Hong Kong
Prior art keywords
rapamycin
huntington
epilepsy
disease
treatment
Prior art date
Application number
HK98110870A
Inventor
Stephen Shi-Hsun Lin
Katherine Lu Molnar-Kimber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HK1009938A1 publication Critical patent/HK1009938A1/en

Links

HK98110870A 1995-12-07 1998-09-23 Product comprising rapamycin or particular derivatives and an nmda or ampa antagonist for use for the treatment of epilepsy or huntington's disease, and the use of rapamycin or particular derivatives for the manufacture of a medicament for the treatment of epilepsy or huntington's disease HK1009938A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83379595A 1995-12-07 1995-12-07

Publications (1)

Publication Number Publication Date
HK1009938A1 true HK1009938A1 (en) 1999-06-11

Family

ID=28455244

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110870A HK1009938A1 (en) 1995-12-07 1998-09-23 Product comprising rapamycin or particular derivatives and an nmda or ampa antagonist for use for the treatment of epilepsy or huntington's disease, and the use of rapamycin or particular derivatives for the manufacture of a medicament for the treatment of epilepsy or huntington's disease

Country Status (1)

Country Link
HK (1) HK1009938A1 (en)

Similar Documents

Publication Publication Date Title
SI0778023T1 (en) Product comprising rapamycin or particular derivatives and an NMDA or AMPA antagonist for use for the treatment of epilepsy or Huntington's Disease, and the use of rapamycin or particular derivatives for the manufacture of a medicament for the treatment of epilepsy or Huntington's Disease.
HK1008180A1 (en) Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
IL119552A0 (en) Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicaments comprising them
AU5802196A (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
IL123013A0 (en) Five-membered heterocycles having biphenylsulfonyl substitution process for their preparation their use as a medicament or diagnostic and medicaments comprising them
HUP9802677A3 (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
IL119417A0 (en) Drug for Parkinson's disease
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
ZA963893B (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament of diagnostic, and medicament containing them.
AU6066896A (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them
AU3728095A (en) Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis
ZA968091B (en) Substituted benzolyguanidines a process for their preparation their use as a medicament or diagnostic agent and medicament comprising them
ZA961231B (en) Substituted benzenesulfonyllureas and -thioureas process for their preparation their use as a medicament or diagnostic and medicament containing them
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
EP0791358A4 (en) Remedy for ophthalmic diseases
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
AU2787495A (en) Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
AU6369396A (en) Drug for ameliorating brain diseases
EP0790062A4 (en) Remedy for heart diseases
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
HK1009938A1 (en) Product comprising rapamycin or particular derivatives and an nmda or ampa antagonist for use for the treatment of epilepsy or huntington's disease, and the use of rapamycin or particular derivatives for the manufacture of a medicament for the treatment of epilepsy or huntington's disease
EP0783891A4 (en) Remedy for bone diseases

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20061204